World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
88
Citations
29305
World Ranking
13134
National Ranking
6699

Overview

Paul A. Meyers is affiliated with Memorial Sloan Kettering Cancer Center in the United States. Their research spans multiple areas within medicine and biochemistry, genetics, and molecular biology.

The scientific publication record of Paul A. Meyers highlights contributions to several fields, with significant focus on pulmonary and respiratory medicine, molecular biology, cancer research, oncology, and neurology. These are supported by a range of subfields and topics associated with their work, including:

  • Sarcoma Diagnosis and Treatment
  • Cancer Genomics and Diagnostics
  • Protein Degradation and Inhibitors
  • Neuroblastoma Research and Treatments
  • Vascular Tumors and Angiosarcomas
  • Molecular Biology Techniques and Applications
  • Cancer-related Gene Regulation

Paul A. Meyers has appeared as a coauthor alongside several frequent collaborators. The most notable include:

  • William D. Tap
  • Emily K. Slotkin
  • Leonard H. Wexler
  • Julia Glade Bender
  • Filemon S. Dela Cruz

Their research has been disseminated through multiple well-known scientific journals. The primary publication venues with repeated contributions are:

  • Journal of Clinical Oncology
  • Cancer Research
  • Clinical Cancer Research
  • Pediatric Blood & Cancer
  • JCO Precision Oncology

Among recent published papers, the following are notable examples illustrating the breadth of research topics and their respective venues and publication years:

  • Extracellular Vesicle and Particle Biomarkers Define Multiple Human Cancers, 2020, Cell
  • Clinical Sequencing of Soft Tissue and Bone Sarcomas Delineates Diverse Genomic Landscapes and Potential Therapeutic Targets, 2022, Nature Communications
  • Prospective Pan-Cancer Germline Testing Using MSK-IMPACT Informs Clinical Translation in 751 Patients with Pediatric Solid Tumors, 2021, Nature Cancer
  • DICER1-associated Central Nervous System Sarcoma in Children: Comprehensive Clinicopathologic and Genetic Analysis of a Newly Described Rare Tumor, 2020, Modern Pathology
  • The Clinical Heterogeneity of Round Cell Sarcomas with EWSR1/FUS Gene Fusions: Impact of Gene Fusion Type on Clinical Features and Outcome, 2020, Genes Chromosomes and Cancer

Best Publications

  • Addition of ifosfamide and etoposide to standard chemotherapy for Ewing's sarcoma and primitive neuroectodermal tumor of bone.

    Holcombe E Grier;Mark D Krailo;Nancy J Tarbell;Michael P Link

  • Osteosarcoma treatment - where do we stand? A state of the art review.

    Anja Luetke;Paul A. Meyers;Ian Lewis;Heribert Juergens

  • Extracellular Vesicle and Particle Biomarkers Define Multiple Human Cancers

    Ayuko Hoshino;Ayuko Hoshino;Han Sang Kim;Han Sang Kim;Linda Bojmar;Linda Bojmar;Linda Bojmar;Kofi Ennu Gyan

  • Chemotherapy for nonmetastatic osteogenic sarcoma: the Memorial Sloan-Kettering experience.

    P A Meyers;G Heller;J Healey;A Huvos

  • Osteosarcoma: The Addition of Muramyl Tripeptide to Chemotherapy Improves Overall Survival—A Report From the Children's Oncology Group

    Paul A. Meyers;Cindy L. Schwartz;Mark D. Krailo;John H. Healey

  • Osteosarcoma: A Randomized, Prospective Trial of the Addition of Ifosfamide and/or Muramyl Tripeptide to Cisplatin, Doxorubicin, and High-Dose Methotrexate

    Paul A. Meyers;Cindy L. Schwartz;Mark Krailo;Eugenie S. Kleinerman

  • EWS-FLI1 fusion transcript structure is an independent determinant of prognosis in Ewing's sarcoma.

    E. De Alava;A. Kawai;J. H. Healey;I. Fligman

  • Comparison of MAPIE versus MAP in patients with a poor response to preoperative chemotherapy for newly diagnosed high-grade osteosarcoma (EURAMOS-1): an open-label, international, randomised controlled trial

    Neyssa M Marina;Sigbjørn Smeland;Stefan S Bielack;Mark Bernstein

  • Survival and prognosis with osteosarcoma: outcomes in more than 2000 patients in the EURAMOS-1 (European and American Osteosarcoma Study) cohort

    Sigbjørn Smeland;Stefan S. Bielack;Jeremy Whelan;Mark Bernstein

  • Methotrexate, Doxorubicin, and Cisplatin (MAP) Plus Maintenance Pegylated Interferon Alfa-2b Versus MAP Alone in Patients With Resectable High-Grade Osteosarcoma and Good Histologic Response to Preoperative MAP: First Results of the EURAMOS-1 Good Response Randomized Controlled Trial

    Stefan S. Bielack;Sigbjørn Smeland;Jeremy S. Whelan;Neyssa Marina

  • Osteogenic sarcoma with clinically detectable metastasis at initial presentation.

    P. A. Meyers;G. Heller;J. H. Healey;A. Huvos

  • Desmoplastic small round-cell tumor: prolonged progression-free survival with aggressive multimodality therapy.

    B. H. Kushner;M. P. Laquaglia;N. Wollner;P. A. Meyers

  • R1507, a Monoclonal Antibody to the Insulin-Like Growth Factor 1 Receptor, in Patients With Recurrent or Refractory Ewing Sarcoma Family of Tumors: Results of a Phase II Sarcoma Alliance for Research Through Collaboration Study

    Alberto S. Pappo;Shreyaskumar R. Patel;John Crowley;Denise K. Reinke

  • Dickkopf 3 Inhibits Invasion and Motility of Saos-2 Osteosarcoma Cells by Modulating the Wnt-β-Catenin Pathway

    Bang H. Hoang;Tadahiko Kubo;John H. Healey;Rui Yang

  • Intensification of preoperative chemotherapy for osteogenic sarcoma: results of the Memorial Sloan-Kettering (T12) protocol.

    Paul A. Meyers;Richard Gorlick;Glenn Heller;Ephraim Casper

  • Expression of HER2/erbB-2 Correlates With Survival in Osteosarcoma

    Richard Gorlick;Andrew G. Huvos;Glenn Heller;Alex Aledo

  • Prevalence and Spectrum of Germline Mutations of the p53 Gene among Patients with Sarcoma

    Junya Toguchida;Toshikazu Yamaguchi;Siri H. Dayton;Roberta L. Beaughamp

  • A recurrent germline PAX5 mutation confers susceptibility to pre-B cell acute lymphoblastic leukemia

    Sohela Shah;Kasmintan A. Schrader;Esmé Waanders;Andrew E. Timms

  • EURAMOS-1, an international randomised study for osteosarcoma: results from pre-randomisation treatment

    J. S. Whelan;S. S. Bielack;N. Marina;S. Smeland

  • Ewing Sarcomas With p53 Mutation or p16/p14ARF Homozygous Deletion: A Highly Lethal Subset Associated With Poor Chemoresponse

    Hsuan Ying Huang;Peter B. Illei;Zhiquan Zhao;Madhu Mazumdar

Frequent Co-Authors

John H. Healey
John H. Healey Memorial Sloan Kettering Cancer Center
Richard Gorlick
Richard Gorlick The University of Texas MD Anderson Cancer Center
Andrew G. Huvos
Andrew G. Huvos Memorial Sloan Kettering Cancer Center
Mark Krailo
Mark Krailo University of Southern California
Holcombe E. Grier
Holcombe E. Grier Harvard University
Michael P. LaQuaglia
Michael P. LaQuaglia Memorial Sloan Kettering Cancer Center
Suzanne L. Wolden
Suzanne L. Wolden Memorial Sloan Kettering Cancer Center
Marc Ladanyi
Marc Ladanyi Memorial Sloan Kettering Cancer Center
Mark C. Gebhardt
Mark C. Gebhardt Harvard Medical School
Cristina R. Antonescu
Cristina R. Antonescu Memorial Sloan Kettering Cancer Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring medicine in the USA opens up many online education and career options in the healthcare field. For those interested in nursing, many students consider the cheapest accredited online rn to bsn programs to advance their credentials without accruing substantial debt.

Prospective students from non-nursing backgrounds might look into specialized online direct entry msn programs for non-nursing majors, which provide a streamlined path to a master’s degree in nursing. Entry-level pathways are also available—such as online adn programs—that can help you start a nursing career more quickly.

Not everyone chooses a clinical route. Administrative careers are a great fit for those interested in healthcare, and accredited medical billing and coding schools online with financial aid are available, making education more accessible for future healthcare administrators. Each of these pathways aligns with the growing need for healthcare professionals in the United States.

Best Scientists Citing Paul A. Meyers

Trending Scientists